Study | Treatment Group (T) | PCV2 colonized lymph tissues (immunohistochemistry) a | Lymphoid depletion and/or histiocytic replacement a |
---|---|---|---|
B | T01 | 95.5 (72.1–99.4) | 90.9 (69.1–97.8) |
B | T02 | 18.8 (6.5–43.7) * | 14.3 (4.5–37.0) ** |
B | T03 | 8.8 (2.0–31.6) * | 4.5 (0.6–27.4) ** |
C | T01 | 96.0 (69.0–99.6) | 86.2 (60.6–96.2) |
C | T02 | 56.3 (23.5–43.7) *** | 37.2 (16.9–63.4) *** |
C | T03 | 35.2 (11.3–31.6) *** | 28.1 (11.0–55.3) *** |